Chlorine in PDB 3g70: Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
Enzymatic activity of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
All present enzymatic activity of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors:
3.4.23.15;
Protein crystallography data
The structure of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors, PDB code: 3g70
was solved by
O.Bezencon,
D.Bur,
L.Prade,
T.Weller,
C.Boss,
W.Fischli,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
36.98 /
2.00
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
65.730,
89.460,
118.370,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.6 /
26.3
|
Other elements in 3g70:
The structure of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
(pdb code 3g70). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 6 binding sites of Chlorine where determined in the
Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors, PDB code: 3g70:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
Chlorine binding site 1 out
of 6 in 3g70
Go back to
Chlorine Binding Sites List in 3g70
Chlorine binding site 1 out
of 6 in the Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl342
b:43.3
occ:1.00
|
CLA
|
A:A5T342
|
0.0
|
43.3
|
1.0
|
C36
|
A:A5T342
|
1.8
|
39.3
|
1.0
|
C33
|
A:A5T342
|
2.7
|
39.0
|
1.0
|
C38
|
A:A5T342
|
2.8
|
38.8
|
1.0
|
CLR3
|
A:A5T342
|
3.1
|
40.1
|
1.0
|
NE2
|
A:GLN19
|
3.5
|
22.5
|
1.0
|
CA
|
A:ALA122
|
3.6
|
21.1
|
1.0
|
N
|
A:ALA122
|
3.7
|
25.6
|
1.0
|
CB
|
A:ALA122
|
3.9
|
20.4
|
1.0
|
O
|
A:PRO118
|
4.0
|
29.6
|
1.0
|
CD
|
A:GLN19
|
4.0
|
23.0
|
1.0
|
C32
|
A:A5T342
|
4.0
|
38.4
|
1.0
|
C37
|
A:A5T342
|
4.1
|
39.5
|
1.0
|
C
|
A:LEU121
|
4.1
|
28.9
|
1.0
|
O
|
A:HOH401
|
4.3
|
31.1
|
1.0
|
O
|
A:LEU121
|
4.4
|
27.2
|
1.0
|
CB
|
A:PRO118
|
4.4
|
26.8
|
1.0
|
CE1
|
A:PHE124
|
4.5
|
23.4
|
1.0
|
OE1
|
A:GLN19
|
4.5
|
22.5
|
1.0
|
CG
|
A:GLN19
|
4.6
|
21.4
|
1.0
|
C34
|
A:A5T342
|
4.6
|
40.1
|
1.0
|
CZ
|
A:PHE124
|
4.6
|
22.6
|
1.0
|
CB
|
A:LEU121
|
4.7
|
33.9
|
1.0
|
C
|
A:PRO118
|
4.7
|
28.4
|
1.0
|
O
|
A:HOH380
|
4.8
|
40.9
|
1.0
|
CA
|
A:LEU121
|
4.9
|
30.8
|
1.0
|
|
Chlorine binding site 2 out
of 6 in 3g70
Go back to
Chlorine Binding Sites List in 3g70
Chlorine binding site 2 out
of 6 in the Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl342
b:40.1
occ:1.00
|
CLR3
|
A:A5T342
|
0.0
|
40.1
|
1.0
|
C33
|
A:A5T342
|
1.8
|
39.0
|
1.0
|
C36
|
A:A5T342
|
2.7
|
39.3
|
1.0
|
C32
|
A:A5T342
|
2.8
|
38.4
|
1.0
|
C29
|
A:A5T342
|
3.0
|
36.9
|
1.0
|
CLA
|
A:A5T342
|
3.1
|
43.3
|
1.0
|
CD1
|
A:PHE119
|
3.4
|
26.1
|
1.0
|
CE1
|
A:PHE119
|
3.6
|
27.9
|
1.0
|
CG
|
A:PRO118
|
3.8
|
26.8
|
1.0
|
CB
|
A:ALA122
|
4.0
|
20.4
|
1.0
|
C38
|
A:A5T342
|
4.1
|
38.8
|
1.0
|
C34
|
A:A5T342
|
4.1
|
40.1
|
1.0
|
F1
|
A:A5T342
|
4.1
|
40.2
|
1.0
|
CZ
|
A:PHE124
|
4.1
|
22.6
|
1.0
|
CA
|
A:PHE119
|
4.2
|
27.5
|
1.0
|
C9
|
A:A5T342
|
4.2
|
39.8
|
1.0
|
CB
|
A:PRO118
|
4.2
|
26.8
|
1.0
|
C
|
A:PRO118
|
4.3
|
28.4
|
1.0
|
N
|
A:PHE119
|
4.3
|
26.2
|
1.0
|
O
|
A:PRO118
|
4.3
|
29.6
|
1.0
|
CG
|
A:PHE119
|
4.3
|
26.5
|
1.0
|
N26
|
A:A5T342
|
4.4
|
31.0
|
1.0
|
C6
|
A:A5T342
|
4.6
|
40.0
|
1.0
|
C37
|
A:A5T342
|
4.6
|
39.5
|
1.0
|
CZ
|
A:PHE119
|
4.7
|
27.5
|
1.0
|
CE2
|
A:PHE124
|
4.7
|
25.4
|
1.0
|
CB
|
A:PHE119
|
4.8
|
26.2
|
1.0
|
C31
|
A:A5T342
|
4.8
|
25.8
|
1.0
|
C28
|
A:A5T342
|
4.8
|
30.0
|
1.0
|
CD
|
A:PRO118
|
4.9
|
28.6
|
1.0
|
CA
|
A:PRO118
|
4.9
|
26.9
|
1.0
|
CA
|
A:ALA122
|
4.9
|
21.1
|
1.0
|
CE1
|
A:PHE124
|
4.9
|
23.4
|
1.0
|
|
Chlorine binding site 3 out
of 6 in 3g70
Go back to
Chlorine Binding Sites List in 3g70
Chlorine binding site 3 out
of 6 in the Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl342
b:42.6
occ:1.00
|
CL11
|
A:A5T342
|
0.0
|
42.6
|
1.0
|
C2
|
A:A5T342
|
1.8
|
39.0
|
1.0
|
C3
|
A:A5T342
|
2.7
|
39.2
|
1.0
|
C4
|
A:A5T342
|
2.8
|
38.5
|
1.0
|
O5
|
A:A5T342
|
2.8
|
38.9
|
1.0
|
F2
|
A:A5T342
|
3.1
|
38.5
|
1.0
|
O
|
A:ASP125
|
3.5
|
22.9
|
1.0
|
CG2
|
A:VAL111
|
3.6
|
23.5
|
1.0
|
CE
|
A:MET114
|
3.7
|
29.5
|
1.0
|
N
|
A:PRO47
|
3.9
|
20.9
|
1.0
|
CG
|
A:PRO47
|
4.0
|
22.1
|
1.0
|
SD
|
A:MET114
|
4.0
|
32.3
|
1.0
|
CD
|
A:PRO47
|
4.0
|
19.9
|
1.0
|
C6
|
A:A5T342
|
4.0
|
40.0
|
1.0
|
C8
|
A:A5T342
|
4.1
|
36.5
|
1.0
|
CB
|
A:VAL111
|
4.1
|
21.2
|
1.0
|
C7
|
A:A5T342
|
4.1
|
39.4
|
1.0
|
C
|
A:VAL46
|
4.1
|
20.1
|
1.0
|
CA
|
A:PRO47
|
4.3
|
21.6
|
1.0
|
CB
|
A:PRO47
|
4.5
|
20.2
|
1.0
|
C10
|
A:A5T342
|
4.5
|
37.0
|
1.0
|
CA
|
A:VAL46
|
4.5
|
22.0
|
1.0
|
CG1
|
A:VAL111
|
4.6
|
24.3
|
1.0
|
C9
|
A:A5T342
|
4.6
|
39.8
|
1.0
|
O
|
A:VAL46
|
4.6
|
21.1
|
1.0
|
C
|
A:ASP125
|
4.7
|
24.6
|
1.0
|
CA
|
A:GLY126
|
4.7
|
22.4
|
1.0
|
O
|
A:TRP45
|
4.8
|
23.6
|
1.0
|
CB
|
A:TRP45
|
4.9
|
25.4
|
1.0
|
N
|
A:VAL46
|
4.9
|
22.8
|
1.0
|
C
|
A:TRP45
|
4.9
|
21.6
|
1.0
|
|
Chlorine binding site 4 out
of 6 in 3g70
Go back to
Chlorine Binding Sites List in 3g70
Chlorine binding site 4 out
of 6 in the Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl342
b:43.3
occ:1.00
|
CLA
|
B:A5T342
|
0.0
|
43.3
|
1.0
|
C36
|
B:A5T342
|
1.8
|
41.5
|
1.0
|
C33
|
B:A5T342
|
2.7
|
40.6
|
1.0
|
C38
|
B:A5T342
|
2.8
|
38.0
|
1.0
|
CLR3
|
B:A5T342
|
3.1
|
41.8
|
1.0
|
CB
|
B:ALA122
|
3.6
|
27.8
|
1.0
|
CA
|
B:ALA122
|
3.7
|
30.1
|
1.0
|
NE2
|
B:GLN19
|
3.8
|
28.7
|
1.0
|
O
|
B:PRO118
|
3.9
|
31.9
|
1.0
|
N
|
B:ALA122
|
4.0
|
31.0
|
1.0
|
C32
|
B:A5T342
|
4.0
|
40.1
|
1.0
|
C37
|
B:A5T342
|
4.1
|
40.1
|
1.0
|
CD
|
B:GLN19
|
4.1
|
25.1
|
1.0
|
CZ
|
B:PHE124
|
4.3
|
23.1
|
1.0
|
CB
|
B:PRO118
|
4.3
|
34.4
|
1.0
|
C
|
B:LEU121
|
4.4
|
35.9
|
1.0
|
O
|
B:LEU121
|
4.4
|
35.8
|
1.0
|
CE1
|
B:PHE124
|
4.4
|
23.0
|
1.0
|
O
|
B:HOH347
|
4.4
|
19.9
|
1.0
|
CG
|
B:GLN19
|
4.6
|
25.1
|
1.0
|
C34
|
B:A5T342
|
4.6
|
39.8
|
1.0
|
OE1
|
B:GLN19
|
4.6
|
27.1
|
1.0
|
C
|
B:PRO118
|
4.7
|
32.3
|
1.0
|
CG
|
B:PRO118
|
4.7
|
35.7
|
1.0
|
|
Chlorine binding site 5 out
of 6 in 3g70
Go back to
Chlorine Binding Sites List in 3g70
Chlorine binding site 5 out
of 6 in the Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl342
b:41.8
occ:1.00
|
CLR3
|
B:A5T342
|
0.0
|
41.8
|
1.0
|
C33
|
B:A5T342
|
1.8
|
40.6
|
1.0
|
C36
|
B:A5T342
|
2.7
|
41.5
|
1.0
|
C32
|
B:A5T342
|
2.8
|
40.1
|
1.0
|
C29
|
B:A5T342
|
3.0
|
35.2
|
1.0
|
CLA
|
B:A5T342
|
3.1
|
43.3
|
1.0
|
CD1
|
B:PHE119
|
3.6
|
31.7
|
1.0
|
CZ
|
B:PHE124
|
3.8
|
23.1
|
1.0
|
F1
|
B:A5T342
|
3.9
|
40.9
|
1.0
|
CG
|
B:PRO118
|
3.9
|
35.7
|
1.0
|
CB
|
B:ALA122
|
3.9
|
27.8
|
1.0
|
CE1
|
B:PHE119
|
4.0
|
32.5
|
1.0
|
C38
|
B:A5T342
|
4.1
|
38.0
|
1.0
|
C34
|
B:A5T342
|
4.1
|
39.8
|
1.0
|
C9
|
B:A5T342
|
4.1
|
42.4
|
1.0
|
CA
|
B:PHE119
|
4.2
|
30.4
|
1.0
|
CE2
|
B:PHE124
|
4.3
|
22.9
|
1.0
|
O
|
B:PRO118
|
4.3
|
31.9
|
1.0
|
N26
|
B:A5T342
|
4.4
|
30.7
|
1.0
|
C
|
B:PRO118
|
4.4
|
32.3
|
1.0
|
C6
|
B:A5T342
|
4.4
|
42.5
|
1.0
|
CG
|
B:PHE119
|
4.4
|
30.5
|
1.0
|
CB
|
B:PRO118
|
4.5
|
34.4
|
1.0
|
N
|
B:PHE119
|
4.5
|
30.2
|
1.0
|
C31
|
B:A5T342
|
4.5
|
26.2
|
1.0
|
C37
|
B:A5T342
|
4.6
|
40.1
|
1.0
|
C28
|
B:A5T342
|
4.8
|
28.4
|
1.0
|
CB
|
B:PHE119
|
4.8
|
30.9
|
1.0
|
CD
|
B:PRO118
|
4.8
|
34.0
|
1.0
|
CE1
|
B:PHE124
|
4.8
|
23.0
|
1.0
|
CA
|
B:ALA122
|
5.0
|
30.1
|
1.0
|
|
Chlorine binding site 6 out
of 6 in 3g70
Go back to
Chlorine Binding Sites List in 3g70
Chlorine binding site 6 out
of 6 in the Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl342
b:44.2
occ:1.00
|
CL11
|
B:A5T342
|
0.0
|
44.2
|
1.0
|
C2
|
B:A5T342
|
1.8
|
42.3
|
1.0
|
C3
|
B:A5T342
|
2.8
|
42.1
|
1.0
|
C4
|
B:A5T342
|
2.8
|
42.6
|
1.0
|
O5
|
B:A5T342
|
3.0
|
41.5
|
1.0
|
F2
|
B:A5T342
|
3.1
|
42.2
|
1.0
|
O
|
B:ASP125
|
3.4
|
31.1
|
1.0
|
CG2
|
B:VAL111
|
3.6
|
32.2
|
1.0
|
CE
|
B:MET114
|
3.7
|
40.8
|
1.0
|
C8
|
B:A5T342
|
3.7
|
37.8
|
1.0
|
N
|
B:PRO47
|
3.9
|
29.1
|
1.0
|
SD
|
B:MET114
|
3.9
|
41.5
|
1.0
|
CB
|
B:VAL111
|
3.9
|
32.4
|
1.0
|
CD
|
B:PRO47
|
4.0
|
31.1
|
1.0
|
CG
|
B:PRO47
|
4.0
|
29.5
|
1.0
|
C6
|
B:A5T342
|
4.0
|
42.5
|
1.0
|
C
|
B:VAL46
|
4.1
|
30.4
|
1.0
|
C7
|
B:A5T342
|
4.1
|
41.9
|
1.0
|
CG1
|
B:VAL111
|
4.3
|
29.2
|
1.0
|
CA
|
B:PRO47
|
4.3
|
30.6
|
1.0
|
CB
|
B:PRO47
|
4.3
|
31.0
|
1.0
|
CA
|
B:VAL46
|
4.5
|
29.1
|
1.0
|
C
|
B:ASP125
|
4.5
|
28.1
|
1.0
|
O
|
B:VAL46
|
4.6
|
29.5
|
1.0
|
C10
|
B:A5T342
|
4.6
|
34.3
|
1.0
|
C9
|
B:A5T342
|
4.6
|
42.4
|
1.0
|
CA
|
B:GLY126
|
4.7
|
24.2
|
1.0
|
O
|
B:TRP45
|
4.8
|
23.7
|
1.0
|
N
|
B:VAL46
|
4.9
|
25.8
|
1.0
|
CB
|
B:TRP45
|
4.9
|
30.8
|
1.0
|
C
|
B:TRP45
|
4.9
|
26.4
|
1.0
|
|
Reference:
O.Bezencon,
D.Bur,
T.Weller,
S.Richard-Bildstein,
L.Remen,
T.Sifferlen,
O.Corminboeuf,
C.Grisostomi,
C.Boss,
L.Prade,
S.Delahaye,
A.Treiber,
P.Strickner,
C.Binkert,
P.Hess,
B.Steiner,
W.Fischli.
Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors J.Med.Chem. V. 52 3689 2009.
ISSN: ISSN 0022-2623
PubMed: 19358611
DOI: 10.1021/JM900022F
Page generated: Sat Jul 20 20:04:32 2024
|